<DOC>
	<DOCNO>NCT00243191</DOCNO>
	<brief_summary>The purpose study examine effect imatinib dermatofibrosarcoma protuberan tumor .</brief_summary>
	<brief_title>Neoadjuvant Imatinib Dermatofibrosarcoma Protuberans</brief_title>
	<detailed_description />
	<mesh_term>Dermatofibrosarcoma</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Inclusion criterion : 1 . Patients â‰¥ equal 18 year age . 2 . Suspected documented diagnosis dermatofibrosarcoma protuberans ( DFSP ) . Patients suspect diagnosis DSFP must DFSP confirm pathology local institution prior dispense start imatinib . 3 . Patient medically able undergo surgical resection DFSP resection DFSP recommend clinical management disease . 4 . Patient least one site measurable ( macroscopic ) disease . 5 . Performance status 0 , 1 2 Eastern Cooperative Oncology Group ( ECOG ) ( see Section 7.1 ) . 6 . Adequate end organ function , define follow : total bilirubin &lt; 1.5 x institutional upper limit normal ( ULN ) , SGOT SGPT &lt; 2.5 x UNL , creatinine &lt; 1.5 x ULN , absolute neutrophil count &gt; 1.5 x 109/L , platelet &gt; 100 x 109/L . 7 . Female patient childbearing potential must negative pregnancy test within 7 day initiation study drug dosing . Postmenopausal woman must amenorrheic least 12 month consider nonchildbearing potential . Male female patient reproductive potential must agree employ effective barrier method birth control throughout study 3 month follow discontinuation study drug . 8 . Written , voluntary inform consent . Exclusion criterion : 1 . Patients receive radiation therapy site DFSP prior resection . 2 . Patients Grade III/IV cardiac problem define New York Heart Association Criteria ( i.e. , congestive heart failure , myocardial infarction within 6 month study ) . 3 . Female patient pregnant breastfeeding . 4 . Patients severe and/or uncontrolled medical disease ( i.e. , uncontrolled diabetes , chronic renal disease , active uncontrolled infection ) may worsen imatinib . 5 . Patients know chronic liver disease ( i.e. , chronic active hepatitis , cirrhosis ) . 6 . Patients know diagnosis human immunodeficiency virus ( HIV ) infection . 7 . Patients receive chemotherapy within 4 week prior study entry . 8 . Patients major surgery within 2 week prior study entry . Incisional biopsy partial excision dermatofibrosarcoma protuberans establish diagnosis and/or collect pretreatment tumor tissue qualify major surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>newly diagnose recurrent</keyword>
</DOC>